ONCOLYTICS BIOTECH INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 |
|---|---|---|
| Operating income | -$28.7M | -$25.5M |
| Operating expenses | $28.7M | $25.5M |
| Cash from operations | -$20.1M | -$19.9M |
| Capital expenditure | $6,000 | $174,000 |
| Free cash flow | -$20.1M | -$20.1M |
| Total assets | $7.6M | $13.4M |
| Total liabilities | $11.4M | $10.1M |
Shares outstanding 119.4M · Free float 100.0%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.